What's next for Securities America?

CEO Nagengast says firm sees ‘a lot of opportunity' for growth; snagged a Next Financial team in August

Nov 1, 2010 @ 2:26 pm

By Bruce Kelly

As broker-dealers continue to struggle with a lack of capital, Securities America Inc. sees plenty of opportunity to build its network of independent reps and advisers. And its CEO and president, Jim Nagengast, points to a direct competitor as a potential source.

In August, Steve Bull, a former branch manager with 20 reps under him at Next Financial Group Inc., joined Securities America. When asked about recruiting and mergers and acquisitions in an interview this morning, Mr. Nagengast said, “Next — we see a lot of opportunity there.”

Mr. Bull's group, Verus Capital Partners LLC, has about $225 million in assets under management, according to Securities America.

Barry Knight, CEO and president of Next Financial, did not return calls seeking comment.

In September, Securities America picked up another branch of about 45 reps and managers in control of $500 million in client assets formerly affiliated with Equitas America LLC. That firm is no longer operating as a broker-dealer, Securities America said.

Mr. Nagengast said that Securities America will look to make a couple of small acquisitions in 2011. “We're good at transitioning large branches quickly,” he said. “We're always looking. We're seeing more broker-dealers looking to shut down.”

Management and brokers at Securities America are enmeshed in legal battles stemming from the firm's sale of private placements up until 2008.

For more than a month, Securities America and the Massachusetts Securities Division have locked horns in Boston over the regulator's charges that the firm misled 60 investors in the state who bought $7.2 million in Medical Capital Holdings Inc. notes from the firm's reps.

That administrative hearing, which began in September, follows a January lawsuit in which Massachusetts regulators alleged that the firm failed to reveal potential red flags to advisers and clients about Medical Capital, which used the notes' proceeds to purchase medical receivables. The Securities and Exchange Commission in 2009 charged Medical Capital with fraud. The company is now in receivership.

Last week, Mr. Nagengast testified in the hearing pitting the Massachusetts regulator against Securities America. On Monday morning, he declined to comment about his testimony, saying, “We feel very strongly we did industry leading due diligence and are vigorously defending” the firm and its advisers.

0
Comments

What do you think?

View comments

Recommended for you

B-D Data Center

Use InvestmentNews' B-D Data Center to find exclusive information and intelligence about the independent broker-dealer industry.

Rank Broker-dealers by

Featured video

Gadget Girl

Orion's Clarke: Why integration is paramount for RIAs right now

Orion has tapped into a huge demand for customizable, integrated solutions that let advisers spend more time building their business. Hear from Eric Clarke and two of Orion's integrated partners to get their thoughts.

Latest news & opinion

Meet our 2017 Women to Watch

Introducing 20 female financial advisers and industry executives who are distinguished leaders, advancing the business of providing advice through their creativity and hard work.

Senate committee approves tax plan but full passage not assured

Several Republican senators expressed reservations about the bill, and the GOP cannot afford too many defections.

House passes tax bill, focus turns to Senate

Tax reform legislation expected to have more of a challenge in upper chamber.

SEC enforcement of advisers drops in Trump era

The agency pursued 82 cases against advisers and firms in fiscal year 2017, down from 98 the previous year.

PIABA accuses Finra of conflicts of interest

Public Investors Arbitration Bar Association report slams self-regulator over its picks for board of governors.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print